Siemens Healthineers and the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), announced a partnership at the World Health Summit today to accelerate the use of artificial intelligence (AI) in diagnosing tuberculosis (TB), a prev...
Three key organizations involved in preventing and responding to HIV in South Africa – AIDS Foundation of South Africa, Beyond Zero, and Networking HIV & AIDS Community of Southern Africa – have placed an initial order of 16,000 dapivirine vaginal ri...
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) announced today a new collaboration with Danaher Corporation (Danaher), a global science and technology innovator who will provide Cepheid’s Xpert® MTB/RIF Ultra diagnostic tes...
The Global Fund’s 2023 Results Report released today shows a remarkable acceleration of programmatic results in the fight against HIV, TB and malaria, after losses from the COVID-19 pandemic. However, multiple challenges, including climate change and...
Through its competitive tenders, the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), together with its partners and generic pharmaceutical manufacturers, will be able to offer tenofovir disoproxil fumarate, lamivudine and dolut...
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) is launching a new Revolving Facility to negotiate improved supply terms for global health products for the countries it supports. This financial mechanism uses advanced market...